Trademark Overview
On Wednesday, September 25, 2024, a trademark application was filed for HERMES with the United States Patent and Trademark Office. The USPTO has given the HERMES trademark a serial number of 98768671. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, April 1, 2025. This trademark is owned by 4BASEBIO PLC. The HERMES trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Scientific and laboratory apparatus, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acid research; apparatus, equipment and instruments for the detection and analysis of nucleic acids; kits containing apparatus, devices, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acids research; computer software applications, downloadable; material testing instruments and machines; testing apparatus not for medical purposes; diagnostic apparatus, not for medical purposes; chemistry apparatus and instruments; DNA chips; surveying apparatus and instruments; laboratory bioreactors; genetic testing apparatus for scientific use; laboratory apparatus for detecting genetic sequences; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for th...
Chemicals for use in medical laboratories and/or for medical diagnostic purposes; therapeutic and diagnostic preparations and reagents for use in medical laboratories and/or for medical diagnostic purposes; biochemical, biological, biotechnological reagents, preparations and substances for use in medical laboratories and/or for medical diagnostic purposes; vaccine preparations; proteins for use in recombinant DNA technology for use in medical laboratories and/or for medical diagnostic purposes; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Chemical, biochemical, biological, biotechnological reagents, preparations and substances for laboratory use in the fields of life science, biotechnology and genomics; diagnostic and laboratory reagents, preparations and substances, for scientific use in the fields of life science, biotechnology and genomics; enzyme preparations for industrial purposes; enzymes for industrial purposes; industrial chemicals; biochemical catalysts; diagnostic preparations, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes; proteins for use in recombinant DNA technology, other than for medical use; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Laboratory research services in the fields of life science, biotechnology and genomics; scientific research services in the fields of life science, biotechnology and genomics; biological, biotechnological, chemical and biochemical research, analysis and development services in the fields of life science, biotechnology and genomics; contract research services in the fields of life science, biotechnology and genomics; nucleic acids discovery, analysis and research and development services; nucleic acids and genomics research and development services for drugs and pharmaceutical discovery and research; nucleic acids production, processing and purification services; consultancy services relating to nucleic acids and genomics; research services for nucleic acids for therapeutic or diagnostic use; purification and production of nucleic acids for therapeutic or diagnostic use; design and manufacture of synthetic DNA, genes and oligonucleotides for others; genetic research; research and develo...
